Luminal A Breast Cancer: How Feasible is Omitting Axillary Dissection Without Neoadjuvant Therapy

Table 1

Patients’ characteristics.

Variables
Age	Mean ± SD	56.74 ± 10.89
Adjuvant CT, n(%)	No	139 (51.3)
	Yes	132 (48.7)
Adjuvant endocrine therapy, n(%)	No	0 (0)
	Yes	271 (100.0)
Mortality, n(%)	No	268 (98.9)
	Yes	3 (1.1)
Local recurrence, n(%)	No	270 (99.6)
	Yes	1 (0.4)
Distant metastasis, n(%)	No	267 (98.5)
	Yes	4 (1.5)

SLNB : sentinel lymph node metastasis; SLN: sentinel lymph node; AD : axillary dissection; OAD : omitting axillary dissection; ADAS : axillary dissection after sentinel.